-
Cantor On Oncobiologics: 'Biosimilar Play With Potential For Interchangeability'
Tuesday, June 7, 2016 - 10:44am | 284Read More...Cantor analysts, Mara Goldstein and Monica Gorman, believe that there existed Biosimilar play with potential for interchangeability in respect of Oncobiologics Inc (NASDAQ: ONSIU) shares. As a result, the two analysts have initiated the stock with a Buy Rating and kept a price tag of $15.00....
-
Cantor Fitzgerald Downgrades Hyperion After Acquisition
Tuesday, March 31, 2015 - 9:37am | 230Read More...Cantor Fitzgerald on Tuesday issued a company update on Hyperion Therapeutics Inc (NASDAQ: HPTX) after Horizon Pharma PLC (NASDAQ: HZNP) announced that it plans to acquire Hyperion for $46 per share in cash. Cantor Fitzgerald downgraded Hyperion to Hold and increased its price target from $35 to $...
